Accordingly, increased systemic Kyn/Trp ratio and elevated IDO1 activity have been associated with poor prognosis and low survival of patients diagnosed with cervical cancer and glioblastoma multiforme (55, 56). Here, IDO1 is linked to cervical cancer.